Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Montai Health platform enables rapid and repeatable advancement of therapies across multiple diseases.
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
CIBO scales regenerative advanced platform technology that connects growers to incentives and enterprises to growers.
Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Expedition Medicines develops an AI-powered platform that creates small-molecule drugs for previously inaccessible disease targets.
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Invaio Sciences is a technology company that is dedicated to solving pressing agriculture, nutrition, and environmental challenges.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Extuitive is an AI-first business that aims to revolutionize the conception and validation of new consumer goods and creatives.
Terrana's innovative technology platform uses RNA-based plant health solutions to enable resilient agriculture for a world.
Etiome, a company redefining how we detect and preempt disease progression.
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
Indigo is an agricultural technology company that focuses on improving sustainability and profitability in farming practices.
Mirai Bio provides access to end-to-end development capabilities with innovation at every step.
Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.
Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.
Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.
Flagship Pioneering has invested in 70 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Flagship Pioneering's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Artificial Intelligence (AI). The firm invests across 26 different industry categories.
Among tracked funding rounds, Denali Therapeutics received $200.0M in a Post Ipo Debt round. Flagship Pioneering's total known invested capital is $4.9B.
Flagship Pioneering's average investment size is $73.8M across its portfolio of 70 companies.
Recent Flagship Pioneering portfolio additions include Montai Therapeutics, Harbinger Health, CIBO, Cellarity, Seres Therapeutics. These companies were founded in 2020 or later.